These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


6351 related items for PubMed ID: 3540418

  • 1. Establishment of four mouse hybridoma cell lines producing monoclonal antibodies reactive with ras oncogene product p21.
    Kuzumaki N, Oda A, Yamagiwa S, Taniguchi N, Kobayashi H, Oikawa T.
    J Natl Cancer Inst; 1986 Dec; 77(6):1273-9. PubMed ID: 3540418
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [An attempt at using monoclonal antibodies to oncogene products].
    Kuzumaki N.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2205-11. PubMed ID: 3300558
    [Abstract] [Full Text] [Related]

  • 4. Establishment of hybridoma cell line secreting specific monoclonal antibodies against turnip mosaic virus and analysis of properties of the McAb.
    Yang F, Cai S, Xu L, Feng L.
    Chin J Biotechnol; 1992 Jun; 8(4):247-54. PubMed ID: 1343828
    [Abstract] [Full Text] [Related]

  • 5. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG, Sinn E, Carney WP.
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [Abstract] [Full Text] [Related]

  • 6. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW, Lee J, Stone MJ.
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [Abstract] [Full Text] [Related]

  • 7. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185.
    McKenzie SJ, Marks PJ, Lam T, Morgan J, Panicali DL, Trimpe KL, Carney WP.
    Oncogene; 1989 May; 4(5):543-8. PubMed ID: 2566965
    [Abstract] [Full Text] [Related]

  • 8. Characterization of monoclonal antibodies specific to the activated ras p21 with aspartic acid at position 13.
    La Vecchio JA, Hamer PJ, Ng SC, Trimpe KL, Carney WP.
    Oncogene; 1990 Aug; 5(8):1173-8. PubMed ID: 2202949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique.
    Yoshikawa K, Ueda R, Obata Y, Utsumi KR, Notake K, Takahashi T.
    Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722
    [Abstract] [Full Text] [Related]

  • 11. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM, Perantoni AO, Santos E.
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [Abstract] [Full Text] [Related]

  • 12. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
    Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD.
    Cancer Res; 1987 Oct 01; 47(19):5009-13. PubMed ID: 3040237
    [Abstract] [Full Text] [Related]

  • 13. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
    Salgar SK, Paape MJ, Alston-Mills B.
    Am J Vet Res; 1993 Sep 01; 54(9):1415-25. PubMed ID: 8239127
    [Abstract] [Full Text] [Related]

  • 14. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
    Weltman JK, Pedroso P, Johnson SA, Davignon D, Fast LD, Leone LA.
    Cancer Res; 1987 Nov 01; 47(21):5552-6. PubMed ID: 2822229
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody to a human osteogenic sarcoma cell line.
    Lizonová A, Blahová S, Bízik J, Grófová M.
    Arch Geschwulstforsch; 1988 Nov 01; 58(3):151-7. PubMed ID: 3046555
    [Abstract] [Full Text] [Related]

  • 16. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.
    Yang JL, Liu DX, Zhen SJ, Zhou YG, Zhang DJ, Yang LY, Chen HB, Feng Q.
    BMC Cancer; 2016 Feb 20; 16():131. PubMed ID: 26897358
    [Abstract] [Full Text] [Related]

  • 17. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
    Yoshida K, Hamatani K, Koide H, Ikeda H, Nakamura N, Akiyama M, Tsuchiyama H, Nakayama E, Shiku H.
    Cancer Res; 1988 Oct 01; 48(19):5503-9. PubMed ID: 3046740
    [Abstract] [Full Text] [Related]

  • 18. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H, Xu ZL, Wang Y, Yang L, Feng O, Li Y, Wang YM, Zhang GG.
    Hum Antibodies Hybridomas; 1993 Jan 01; 4(1):2-8. PubMed ID: 8381684
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibodies against the GP-2 subunit of laminin.
    Chung AE, Jaffe R, Bender B, Lewis M, Durkin M.
    Lab Invest; 1983 Nov 01; 49(5):576-81. PubMed ID: 6632775
    [Abstract] [Full Text] [Related]

  • 20. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP, Hamer P, Petit D, Wolfe H, Cooper G, Lefebvre M, Rabin H.
    J Cell Biochem; 1986 Nov 01; 32(3):207-14. PubMed ID: 3536974
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 318.